chr7-115984416-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012252.4(TFEC):āc.26A>Gā(p.Asn9Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012252.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TFEC | NM_012252.4 | c.26A>G | p.Asn9Ser | missense_variant | 2/8 | ENST00000265440.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TFEC | ENST00000265440.12 | c.26A>G | p.Asn9Ser | missense_variant | 2/8 | 1 | NM_012252.4 | P4 | |
TFEC | ENST00000320239.11 | c.26A>G | p.Asn9Ser | missense_variant | 2/7 | 1 | A1 | ||
TFEC | ENST00000484212.5 | c.296A>G | p.Asn99Ser | missense_variant | 4/9 | 2 | |||
TFEC | ENST00000393485.5 | c.26A>G | p.Asn9Ser | missense_variant | 2/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250920Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135582
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461806Hom.: 0 Cov.: 32 AF XY: 0.0000468 AC XY: 34AN XY: 727212
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.26A>G (p.N9S) alteration is located in exon 2 (coding exon 1) of the TFEC gene. This alteration results from a A to G substitution at nucleotide position 26, causing the asparagine (N) at amino acid position 9 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at